Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Amgen Inc AMGN

Healthcare Biotechnology
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL... see more

Recent & Breaking News (NDAQ:AMGN)

ROSEN, A TOP RANKED LAW FIRM, Encourages Amgen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMGN

Newsfile April 21, 2023

AMGN SHAREHOLDER ALERT: Jakubowitz Law Reminds Amgen Shareholders of a Lead Plaintiff Deadline of May 12, 2023

PR Newswire April 21, 2023

AMGN CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Investors that a Securities Fraud Class Action Lawsuit Filed against Amgen Inc

Newsfile April 20, 2023

AMGN LAWSUIT ALERT: Levi & Korsinsky Notifies Amgen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire April 20, 2023

AMGEN WINS PATENT APPEAL ON OTEZLA® (APREMILAST)

PR Newswire April 19, 2023

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Amgen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2023 - (NASDAQ: AMGN)

PR Newswire April 19, 2023

Amgen Class Action: Levi & Korsinsky Reminds Amgen Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2023 - AMGN

Newsfile April 18, 2023

NATIONALLY RANKED ROSEN LAW FIRM Encourages Amgen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMGN

Newsfile April 18, 2023

Amgen Shareholder Notice

Newsfile April 18, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amgen Inc. - AMGN

PR Newswire April 18, 2023

AMGN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 12, 2023 in the Class Action Filed on Behalf of Amgen Inc. Shareholders

PR Newswire April 18, 2023

Amgen Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 12, 2023 to Discuss Your Rights - AMGN

Newsfile April 17, 2023

AMGN Investors Have Opportunity to Lead Amgen Inc. Securities Fraud Lawsuit

PR Newswire April 17, 2023

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Amgen Investors of a Lead Plaintiff Deadline of May 12, 2023

PR Newswire April 17, 2023

ROSEN, A LEADING LAW FIRM, Encourages Amgen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMGN

Newsfile April 16, 2023

ROSEN, A TOP RANKED FIRM, Encourages Amgen Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMGN

PR Newswire April 15, 2023

Amgen Shareholder Notice

Newsfile April 14, 2023

AMGN Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Amgen Inc. of Deadline in Securities Fraud Class Action Lawsuit

Newsfile April 14, 2023

AMGN SHAREHOLDER ALERT: Jakubowitz Law Reminds Amgen Shareholders of a Lead Plaintiff Deadline of May 12, 2023

PR Newswire April 14, 2023

AMGN Investors Have Opportunity to Lead Amgen Inc. Securities Fraud Lawsuit

PR Newswire April 13, 2023